RYLCX | VCDAX | RYLCX / VCDAX | |
Total Expense Ratio | 2.40 | 0.09 | 2,667% |
Annual Report Gross Expense Ratio | 2.43 | 0.09 | 2,700% |
Fund Existence | 24 years | 20 years | - |
Gain YTD | 12.287 | -1.625 | -756% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 100000 | 3% |
Min. Initial Investment IRA | 1000 | N/A | - |
Net Assets | 13.2M | 6.47B | 0% |
Annual Yield % from dividends | 0.52 | 0.82 | 64% |
Returns for 1 year | 28.38 | 16.07 | 177% |
Returns for 3 years | 59.46 | 59.50 | 100% |
Returns for 5 years | 44.83 | 83.54 | 54% |
Returns for 10 years | 51.13 | 199.62 | 26% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WSGAX | 13.09 | 0.15 | +1.16% |
Macquarie Small Cap Growth A | |||
BIAYX | 10.53 | 0.07 | +0.67% |
Brown Advisory Sustainable Sml-Cp Cr Inv | |||
CSPFX | 73.86 | 0.43 | +0.59% |
American Funds SMALLCAP World 529F | |||
FBIOX | 18.56 | 0.09 | +0.49% |
Fidelity Select Biotechnology | |||
ISCWX | 94.35 | 0.23 | +0.24% |
Voya Multi-Manager International Sm Cp W |